Contract for Korean Pan-Genome Sequencing (2.49 billion won)
-
Contract signed with Korea National Institute of Health (KDCA) for Korean pan-genome sequencing: 2.49 billion won (73% share, total 3.41 billion won).
-
Represents 12.88% of recent revenue (19.32 billion won).
-
Contract period: May 13, 2026 ~ Dec 11, 2026.
-
No advance payment; payment upon completion of supply.
KOSDAQ Filing Information
-
-
Conclusion of a Single Sales and Supply Contract
-
Company: JS Link (127120)
-
Submission: JS Link, Inc.
-
Under KRX KOSDAQ Market Division
-
-
Shares: 34,573,731
-
Price: 40,250 KRW
-
Market Cap: 1,391.6 B KRW